Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer-A Nationwide, Population-Based, Propensity Score-Matched Cohort Study.

Shih-Yi LinCheng-Li LinCheng-Chieh LinWu-Huei HsuChia-Der LinI-Kuan WangChung-Y HsuChia-Hung Kao

Published in: Cancers (2020)

ACEI use is associated with an increased risk of lung cancer compared with ARB use. Patients using ARBs have a significantly lower risk of lung cancer than non-ARB users.

Keyphrases

angiotensin converting enzyme
end stage renal disease
angiotensin ii
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors